摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

E-3-[4-n-Butyl-3-[(7-carboxy-4-methoxy)naphthyl]thien-2-yl]-2-[(2-methoxy-4,5-methylenedioxyphenyl)methyl]-2-propenoic acid | 531491-81-3

中文名称
——
中文别名
——
英文名称
E-3-[4-n-Butyl-3-[(7-carboxy-4-methoxy)naphthyl]thien-2-yl]-2-[(2-methoxy-4,5-methylenedioxyphenyl)methyl]-2-propenoic acid
英文别名
8-[4-butyl-2-[(E)-2-carboxy-3-(6-methoxy-1,3-benzodioxol-5-yl)prop-1-enyl]thiophen-3-yl]-5-methoxynaphthalene-2-carboxylic acid
E-3-[4-n-Butyl-3-[(7-carboxy-4-methoxy)naphthyl]thien-2-yl]-2-[(2-methoxy-4,5-methylenedioxyphenyl)methyl]-2-propenoic acid化学式
CAS
531491-81-3
化学式
C32H30O8S
mdl
——
分子量
574.651
InChiKey
UPHCFGAMIPRDQU-KGENOOAVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.6
  • 重原子数:
    41
  • 可旋转键数:
    11
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    140
  • 氢给体数:
    2
  • 氢受体数:
    9

文献信息

  • ENDOTHELIN RECEPTOR ANTAGONISTS
    申请人:SMITHKLINE BEECHAM CORPORATION
    公开号:EP0925297A1
    公开(公告)日:1999-06-30
  • EP0925297A4
    申请人:——
    公开号:EP0925297A4
    公开(公告)日:1999-06-30
  • Method and Composition for Potentiating the Antipyretic Action of a Nonopiod Analgesic
    申请人:Gulati Anil
    公开号:US20080207763A1
    公开(公告)日:2008-08-28
    A composition and method of treating fever, and optionally treating pain, is disclosed. The composition and method utilize a nonopioid analgesic and an endothelin antagonist as active agents to treat fever in mammals, including humans. The composition also is useful in the prevention and treatment of stroke and other cardiovascular disorders, like myocardial infarction.
  • Diagnostic Use of Endothelin Etb Receptor Agonists and Eta Receptor Antagonists in Tumor Imaging
    申请人:Gulati Anil
    公开号:US20080260634A1
    公开(公告)日:2008-10-23
    Methods of imaging tumors are disclosed. The methods utilize an endothelin ET B receptor agonist or an endothelin ET A receptor antagonist, in combination with an imaging agent, to detect a tumor in mammals, including humans.
  • Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
    申请人:Gulati Anil
    公开号:US20100173872A1
    公开(公告)日:2010-07-08
    A composition and method of treating Alzheimer's disease or a dementia of vascular origin are disclosed. The composition and method utilize an endothelin antagonist as the active agent to treat Alzheimer's disease or a dementia of vascular origin in mammals, including humans.
查看更多